TimesSquare Capital Management’s Verona Pharma VRNA Stock Holding History

TimesSquare Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63,430	Closed	-$6.77M	–	162
2025 Q3	$6.77M	Sell	63,430 -430,173	-87%	-$44.9M	0.1%	146
2025 Q2	$46.7M	Sell	493,603 -2,948	-0.6%	-$218K	0.67%	59
2025 Q1	$31.5M	Buy	+496,551	New	+$29.7M	0.51%	80

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

TimesSquare Capital Management's VRNA Position: Q4 2025 in Review

TimesSquare Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 63,430 shares — an estimated $6.77M sold.

TimesSquare Capital Management first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $46.7M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

TimesSquare Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
TimesSquare Capital Management sold 63,430 Verona Pharma shares in Q4 2025, an estimated $6.77M.
TimesSquare Capital Management first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
TimesSquare Capital Management's Verona Pharma position peaked at $46.7M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on TimesSquare Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.